共 50 条
- [5] Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis [J]. World Journal of Surgical Oncology, 18
- [9] Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma [J]. FRONTIERS IN ONCOLOGY, 2022, 12